VerImmune Inc., an early-stage biotechnology company specializing in the development of innovative products based on a novel Virus-inspired Particle technology platform, announced the securing of an additional $3.125 million from follow-on Seed financing and a partnership milestone payment.
September 20, 2023
· 2 min read